13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

Page 12 of 18

Page 12 of 18 – SEC Filing

Cusip No. 23291E208 12 of 15
Pages

(3)      Deerfield Private Design Fund IV

Sole power to vote or direct the vote: 0

Shared power to vote or direct the vote:
9,467,500

Sole power to dispose or to direct the disposition:
0

Shared power to dispose or direct the disposition:
9,467,500

(4)      Flynn

Sole power to vote or direct the vote: 0

Shared power to vote or direct the vote:
9,497,500

Sole power to dispose or to direct the disposition:
0

Shared power to dispose or direct the disposition:
9,497,500

(4)      Hochberg

Sole power to vote or direct the vote: 0

Shared power to vote or direct the vote:
6,967,500

Sole power to dispose or to direct the disposition:
0

Shared power to dispose or direct the disposition:
6,967,500

Flynn is the sole member of the general
partner of each of Deerfield Mgmt IV and Deerfield Management. Deerfield Mgmt IV is the general partner, and Deerfield Management
is the investment manager, of Deerfield Private Design Fund IV. Hochberg, an employee of Deerfield Management and a director of
the Company, also serves as Deerfield Private Design Fund IV’s designee on the board of managers of the Sponsor, which consists
of two managers.

Each Reporting Person may be deemed to
be a member of a “group” for purposes of the Exchange Act with the Sponsor and RAB (the other member of the Sponsor),
and Richard Barasch. The Reporting Persons, the Sponsor, RAB and Mr. Barasch may be deemed to collectively beneficially own an
aggregate of 9,497,500 shares of Common Stock, or 30.39% of the issued and outstanding shares of Common Stock. The share ownership
reported for the Reporting Persons does not include any shares of Common Stock held by the other member of the Sponsor or Mr. Barasch.
Each Reporting Person disclaims beneficial ownership of any shares of Common Stock beneficially owned by the other member of the
Sponsor, except with respect to the shares owned by the Sponsor as disclosed in this Schedule 13D.

(c) Except as set forth in Items 3 and
4 of this Schedule 13D, the Reporting Persons have not engaged in any transactions in the Company’s securities during the
past 60 days.

(d) Except as described in this paragraph, as of the date of
this Schedule 13D, no person other than the Reporting Persons is known to the Reporting Persons to have the right to receive or
the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this
Schedule 13D. RAB holds 50% of the outstanding Units of the Sponsor and has designated Richard Barasch as a member of the board
of managers of the Sponsor. Mr. Barasch and Hochberg, as managers of the Sponsor, have the right, acting together, to direct the
receipt of dividends in respect of, and proceeds from the sale of, the Founder Shares in accordance with the terms of the LLC Agreement
(as defined in Item 6 below) of the Sponsor.

Follow Adapthealth Corp.

Page 12 of 18